Stay updated on Safety of SAGE-718 in Huntington's Disease Clinical Trial

Sign up to get notified when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of SAGE-718 in Huntington's Disease Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T03:52:05.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-13T22:10:13.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    50 days ago
    Change Detected
    Summary
    The study has expanded to include 18 locations, and the revision has been updated from v2.9.7 to v2.10.0.
    Difference
    0.4%
    Check dated 2024-07-23T14:07:50.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:14:29.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The website was last updated on July 5, 2024, with the previous estimated update date removed.
    Difference
    0.2%
    Check dated 2024-07-08T22:32:53.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    The website now includes new criteria for participant screening and enrollment in study 718-CIH-301, extending the study duration to up to 48 months from the previous 365 days.
    Difference
    4%
    Check dated 2024-07-05T16:32:58.000Z thumbnail image

Stay in the know with updates to Safety of SAGE-718 in Huntington's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.